The Scientist

» biotechnology

Most Recent

image: Taking Shots at Ebola

Taking Shots at Ebola

By | November 5, 2014

With an infusion of public and private resources and accelerated regulatory processes, a handful of companies are racing to develop a vaccine to curb the Ebola epidemic.

4 Comments

image: Nurse Infected with Ebola in Spain

Nurse Infected with Ebola in Spain

By | October 6, 2014

The case marks the first person to contract the virus outside of West Africa.

0 Comments

image: The Second Coming of RNAi

The Second Coming of RNAi

By | September 1, 2014

Now showing clinical progress against liver diseases, the gene-silencing technique begins to fulfill some of its promises.

1 Comment

image: A Matter of Size

A Matter of Size

By | August 1, 2014

Erroneous characterization of nanomaterials can misinform the study of a new medicine’s safety and efficacy.

0 Comments

image: Nanomedicine

Nanomedicine

By , and | August 1, 2014

From bioimaging to drug delivery and therapeutics, nanotechnology is poised to change the way doctors practice medicine.

10 Comments

image: FDA Approves Prosthetic Arm

FDA Approves Prosthetic Arm

By | May 14, 2014

The agency OKs the first prosthetic arm controlled by neural signals from the user’s muscles.

0 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: DARPA Puts Biotech at the Fore

DARPA Puts Biotech at the Fore

By | April 4, 2014

The U.S. Department of Defense is solidifying its focus on the life sciences with a new division of biotechnology.  

0 Comments

image: Biotech Superstar Dies

Biotech Superstar Dies

By | March 7, 2014

Alejandro Zaffaroni, who launched companies that developed birth control pills, microarrays, and transdermal drug patches, has died at age 91.  

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

Popular Now

  1. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  2. Will Organs-in-a-Dish Ever Replace Animal Models?
  3. Your Office Has a Distinct Microbiome
  4. Neurons Compete to Form Memories
RayBiotech